Invention Grant
- Patent Title: Selective IL-6-trans-signalling inhibitor compositions
-
Application No.: US16675621Application Date: 2019-11-06
-
Publication No.: US11306136B2Publication Date: 2022-04-19
- Inventor: Ian Cottingham , Daniel Plaksin , Jérémy Duboeuf
- Applicant: Ferring B.V.
- Applicant Address: NL Hoofddorp
- Assignee: Ferring B.V.
- Current Assignee: Ferring B.V.
- Current Assignee Address: NL Hoofddorp
- Agency: Choate, Hall & Stewart LLP
- Agent Rolando Medina; Dana M. Daukss
- Priority: EP14195726 20141201
- Main IPC: C07K14/715
- IPC: C07K14/715 ; A61K38/17 ; C12N15/63 ; A61K9/00 ; A61K47/26 ; C07K14/54 ; A61K38/00
Abstract:
A selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6-mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be administered to humans at a variety of doses.
Information query
